Ifp Advisors, Inc Haemonetics Corp Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 13 shares of HAE stock, worth $743. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 10 30.0%

Holding current value

$743

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$71.16 - $93.38 $213 - $280	3 Added 30.0%	13 $1,000
Q3 2023 Oct 12, 2023	SELL	$82.56 - $93.49 $16,759 - $18,978	-203 Reduced 95.31%	10 $0
Q2 2023 Aug 04, 2023	SELL	$80.84 - $89.45 $6,790 - $7,513	-84 Reduced 28.28%	213 $18,000
Q1 2023 Apr 18, 2023	BUY	$72.75 - $90.6 $3,419 - $4,258	47 Added 18.8%	297 $24,000
Q4 2022 Feb 07, 2023	BUY	$73.85 - $86.14 $1,181 - $1,378	16 Added 6.84%	250 $26,000
Q3 2022 Nov 08, 2022	BUY	$63.3 - $78.66 $506 - $629	8 Added 3.54%	234 $24,000
Q2 2022 Sep 06, 2022	BUY	$49.27 - $66.08 $11,135 - $14,934	226 New	226 $21,000
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $11,135 - $14,934	-226 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$43.77 - $63.22 $9,454 - $13,655	216 Added 2160.0%	226 $14,000
Q1 2022 Aug 08, 2022	BUY	$43.77 - $63.22 $437 - $632	10 New	10 $0
Q3 2021 Oct 06, 2021	SELL	$57.6 - $70.59 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$51.81 - $118.56 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$111.01 - $139.48 $58,835 - $73,924	-530 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$88.75 - $119.95 $39,582 - $53,497	446 Added 530.95%	530 $62,000
Q3 2020 Oct 29, 2020	BUY	$75.65 - $93.58 $3,933 - $4,866	52 Added 162.5%	84 $7,000
Q2 2020 Aug 05, 2020	BUY	$84.96 - $118.91 $849 - $1,189	10 Added 45.45%	32 $3,000
Q1 2020 May 12, 2020	BUY	$74.34 - $121.82 $1,635 - $2,680	22 New	22 $3,000
Q4 2019 Jan 17, 2020	SELL	$114.37 - $129.46 $2,973 - $3,365	-26 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$117.16 - $138.52 $1,757 - $2,077	-15 Reduced 36.59%	26 $3,000
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $2,414 - $2,961	29 Added 241.67%	41 $3,000
Q4 2018 Jan 23, 2019	SELL	$90.66 - $116.63 $9,156 - $11,779	-101 Reduced 89.38%	12 $1,000
Q3 2018 Oct 25, 2018	SELL	$89.96 - $114.58 $11,065 - $14,093	-123 Reduced 52.12%	113 $0
Q2 2018 Aug 07, 2018	SELL	$71.53 - $95.75 $10,801 - $14,458	-151 Reduced 39.02%	236 $0
Q1 2018 Jun 03, 2019	BUY	$60.72 - $74.41 $2,185 - $2,678	36 Added 10.26%	387 $22,000
Q1 2018 May 09, 2018	SELL	$60.72 - $74.41 $2,185 - $2,678	-36 Reduced 9.3%	351 $0
Q2 2017 Jun 03, 2019	BUY	N/A	266 Added 219.83%	387 $15,000
Q4 2016 Jun 03, 2019	BUY	N/A	94 Added 348.15%	121 $5,000
Q2 2016 Jun 03, 2019	SELL	N/A	-14 Reduced 34.15%	27 $1,000
Q1 2016 Jun 03, 2019	BUY	N/A	41	41 $3,000

Others Institutions Holding HAE

# of Institutions

345

Shares Held

52M

Call Options Held

600K

Put Options Held

474K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.93B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account